Adverse effects of mouse hepatitis virus on ascites myeloma passage in the BALB/eJ mouse

Laboratory Animal Science
|April 1, 1977
PubMed

Insights

Mouse hepatitis virus (MHV) caused unexpected deaths in mice during tumor passage. Implementing enhanced animal handling procedures and using MHV-negative mice prevented further outbreaks and ensured experimental integrity.

Area of Science:

  • Veterinary Pathology
  • Virology
  • Animal Models

Background:

  • Experimental serial passage of ascites myelomas in BALB/cJ mice led to unexpected morbidity and mortality.
  • Affected mice exhibited liver necrosis and splenomegaly, with negative bacterial cultures.

Purpose of the Study:

  • To identify the cause of unexpected deaths during experimental tumor passage.
  • To implement strategies to prevent future outbreaks and ensure animal model reliability.

Main Methods:

  • Virus isolation from affected mice and myeloma lines.
  • Serologic surveys to assess MHV antibody prevalence.
  • Mouse antibody production assay for other murine viruses.
  • Implementation of modified animal handling procedures and use of MHV-negative mice.

Main Results:

  • Mouse hepatitis virus (MHV) was isolated from sick mice and contaminated ascites myeloma lines.
  • MHV infection proved lethal in nude mice, confirming its pathogenicity.
  • MHV antibodies were detected in mice from holding rooms, indicating a potential source.
  • Modified procedures and MHV-negative mice successfully prevented illness in new tumor lines.

Conclusions:

  • Mouse hepatitis virus (MHV) was the causative agent of the outbreak during experimental tumor passage.
  • Enhanced animal husbandry, including the use of MHV-seronegative mice and improved housing, is critical for maintaining healthy animal models.

Related Concept Videos